Table 2 Baseline characteristics in control, prediabetic, and diabetic groups.
Variables | Control | Prediabetic | Diabetic | p-value |
|---|---|---|---|---|
Number, n (%) | 117 (36%) | 35 (10.77%) | 173 (53.23%) | – |
Age (years) | 38.2 ± 10.7 (65.0) | 36.0 ± 12.1 (60.0) | 48.7 ± 11.7 (85.0) | 0.000 |
Weight (kg) | 66.8 ± 11.1 (98.0) | 65.8 ± 9.8 (93.5) | 63.9 ± 12.1 (105.0) | 0.112 |
Height (cm) | 80.1 ± 81.8 (181.0) | 106.5 ± 77.1 (176.0) | 98.4 ± 76.6 (178.0) | 0.085 |
BMI (kg/m2) | 24.6 ± 3.5 (33.0) | 24.9 ± 3.0 (31.0) | 25.6 ± 4.0 (40.0) | 0.049 |
WC (cm) | 85.1 ± 10.4 (110.0) | 86.0 ± 9.2 (105.0) | 87.1 ± 10.3 (116.0) | 0.438 |
HC (cm) | 92.2 ± 8.3 (113.0) | 93.7 ± 6.1 (108.0) | 91.1 ± 8.2 (113.0) | 0.302 |
SBP (mmHg) | 123.0 ± 13.9 (167.0) | 130.8 ± 15.8 (160.0) | 134.3 ± 18.9 (216.0) | 0.000 |
DBP (mmHg) | 82.6 ± 10.8 (118.0) | 85.4 ± 11.2 (112.0) | 85.2 ± 8.5 (115.0) | 0.066 |
PP (Beats/min) | 75.8 ± 11.9 (122.0) | 79.6 ± 10.9 (106.0) | 83.3 ± 11.2 (124.0) | 0.000 |
FBG (mmol/L) | 4.8 ± 0.4 (5.5) | 6.0 ± 0.4 (6.8) | 10.8 ± 4.5 (26.9) | 0.000 |
XO (U/L) | 2.9 ± 1.8 (8.2) | 3.7 ± 1.9 (7.8) | 5.8 ± 3.6 (18.9) | 0.000 |
SUA (mg/dL) | 6.5 ± 1.8 (12.9) | 6.1 ± 1.7 (9.6) | 4.9 ± 1.9 (10.6) | 0.000 |
Creatinine (mg/dL) | 0.9 ± 0.2 (1.3) | 0.8 ± 0.2 (1.2) | 0.9 ± 0.4 (2.5) | 0.631 |
eGFR (mL/min/1.73 m2) | 92.8 ± 16.7 (149.1) | 91.1 ± 12.1 (114.2) | 86.0 ± 21.4 (147.0) | 0.028 |
SA (g/L) | 50.4 ± 14.4 (94.4) | 48.4 ± 8.0 (68.4) | 42.6 ± 9.2 (67.0) | 0.001 |
TG (mg/dL) | 178.2 ± 96.6 (516.4) | 183.2 ± 113.5 (474.4) | 225.3 ± 138.6 (812.6) | 0.006 |
TC (mg/dL) | 204.3 ± 58.1 (426.1) | 216.4 ± 67.5 (377.7) | 231.9 ± 106.7 (584.0) | 0.041 |
HDL (mg/dL) | 32.6 ± 10.9 (82.0) | 32.6 ± 8.8 (55.0) | 36.6 ± 15.5 (112.4) | 0.044 |
LDL (mg/dL) | 136.2 ± 52.9 (317.2) | 149.1 ± 57.4 (307.5) | 152.1 ± 101.7 (517.2) | 0.290 |
